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Epidermal Hyperplasia in Mouse Skin
Following Treatment with Alternative
Drinking Water Disinfectants
by Merrel Robinson,* Richard J. Bull,t Marlene Schamer,*
and Richard E. Longt
Female SENCAR mice were treated with aqueous solutions of hypochlorous acid (HOCI), sodium hy-
pochlorite (NaOCl), chlorine dioxide (Cl02), andmonochloramine (NH2Cl) bywhole bodyexposure (except
head) for a 10-min period for 4 days in the first experiment and for 1 day (except NH2Cl) in the second
experiment. Animals were sacrificed the day following the last treatment (experiment 1) or on day 1, 2,
3, 4, 5, 8, 10, and 12 following treatment (experiment 2), and skin thickness was measured by light
microscopy at x400 by use of an eyepiece micrometer. Concentrations of disinfectants were 1, 10, 100,
300, and 1000 mg/L, for experiment 1 and 1000 mg[L for experiment 2. Thickness of the interfollicular
epidermis (IFE) for control animals was 15.4 ± 1.5 ,um. Mter 4 days of treatment at 1000 mg/L, HOCI
and C102 increased thickness to 39 ± 7.0 and 40.2 ± 11.8, and NaOCl increased thickness to 25.2 ± 6.1
,m. Only HOCl and C102 were tested at 300 mgIL, yielding an IFE thickness of 30.0 ± 13.1 and 16.8 ±
0.8 ,um, respectively. The response to HOCI was found to be dose-related; the minimally effective dose
was 100 mg/L. In earlier, preliminary tests to determine optimum treatment schedule, the response to
HOCI appeared to be maximal after 4 days of treatment and tended to decrease with further treatment.
The time-course study following a single treatment of 1000 mg/L HOCI, however, showed a progression
of IFE thickening of from 18.3 ± 1.4 at 1 day to 30.8 ± 8.0 at 8 days, decreasing to 19.1 ± 6.2 ,um at 12
days. ClO2 and NaOCl when tested in this manner did not produce increased thickness of IFE with time,
but rather gave a persistent level ofincrease that remained for the 12 days. NH2Cl reduced skin thickness
to 13.6 ± 6.1 ,m. Examination of sections of skin treated with HOCI and Cl02 indicated an increase in
cell numbers. HOCI and C102 are therefore capable ofinducing hyperplastic responses in the mouse skin.
The basis for the decrease in skin thickness resulting from NH2Cl treatment remains to be established.
Introduction
Alternative methods for disinfecting drinking water
supplies are still being considered by the U.S. Envi-
ronmental Protection Agency (EPA) as a means to min-
imize the formation of halogenated by-products asso-
ciated with chlorination. In the past decade it has
becomeincreasinglyapparentthat anumberofpotential
health hazards are associated with disinfection of po-
table water (1). In general, the hazards associated with
ingestion of disinfectants or their by-products have re-
ceived the most attention. Dermal exposure to drinking
water disinfectants is, however, almost universal, and
the toxicology associated with this route must also be
characterized.
Inthe present studies, hypochlorous acid (HOCI), so-
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diumhypochlorite (NaOCI), chlorine dioxide(CIO2), and
monochloramine (NH2Cl) were tested for hyperplasi-
ogenic activity in SENCAR mice. These studies follow
from previous observations that chlorine is capable of
producing hyperplasia (2) and that it can act as a co-
carcinogen in mouse skin (3). Our ultimate purpose is
to clarifythe extenttowhich alternative forms ofdrink-
ing water disinfection may be capable ofpromoting the
growth of tumors in the skin. The present results are
concerned exclusively with the relative degree of pro-
liferative epidermal hyperplasia produced by these
chemicals.
Methods
Chemicals
Sodium hypochlorite (NaOCl) was prepared by bub-
bling chlorine gas into a 40 g/L sodium hydroxide
(NaOH) solution until a pH of 8.5 was achieved. To
obtain the hypochlorite (OCI-) solution, a portion of
NaOCl solution taken to pH 12.0 by continued chlorineROBINSON ET AL.
bubbling was titrated to a pH of6.5 with 2.5 N hydro-
chloric acid (HCl). NH2CI solutions were prepared by
titrating a 1.75% ammonium hydroxide (NH40H) so-
lution with a NaOCI (31 g/L chlorine [Cl]) solution until
a 1.4% NH40H solution was achieved. The resulting
NH2Cl solution was adjusted to the desired concentra-
tion with distilled water, and pH was adjusted to the
desired 8.5 to 8.7 with 2.5 N HCl. CG02 was prepared
bypurgingfromanacidified-NaCI02generator, through
an absorbent NaCl02 column, into distilled deionized
water to the desired concentration. 12-0-Tetradeca-
noylphorbol-13-acetate (TPA) was obtained fromChem-
ical Carcinogenesis Company (Eden Prairie, MN).
Assay
Female SENCAR mice, 6 to 7 weeks of age, were
used in these studies. Three days before beginning
treatment, the backs of the animals were shaved. At
the start of treatment, only those mice found to be in
the resting phase of the hair cycle were used. Treat-
ments with disinfectants or water were administered
using a series of small Plexiglas chambers that were
designed to hold the animals while the compartments
were flooded with test solutions and to protect them
frominhalation ofthe toxic vapors duringthe treatment
procedure. A preliminary time-course study was con-
ducted to determine the most effective treatment du-
ration foryielding epidermalhyperplasia. Inthis study,
five animals per group were exposed to 1000 ppm HOCl
solution for 10 min per day for 1, 2, 3, 4, 5, 7, and 8
days. Based on the results ofthat study, animals in the
primary study were treated for 4 days with 1, 10, 100,
300, or 1000 ppm of HOCI, C102, or NH2Cl, with the
exception that NH2Cl was not tested at 300 ppm. In
addition, NaOCI was tested at 1000 ppm for 4 days of
treatment. Negative controls received distilled water
for the same duration. All whole-body (except head)
exposures consisted ofa 10-min contact time per day of
treatment. TPA was applied topically at a dose of 1.0
p,g in 0.2 mL acetone per mouse and served as the
positive control. In a separate study, asingle treatment
ofHOCI, NaOCI, or C102 was administered in the same
manner, and animals were held for up to 12 days before
sacrifice to determine the time course associated with
the hyperplastic response. This study was conducted in
two phases, each phase containing a separate distilled
water group as a negative control (phase 1, HOCl and
C102; phase 2, NaOCl and TPA). Animals in each study
were sacrificed 24 hr after final treatment, and a 1-cm2
section of dorsal skin was taken from each mouse for
evaluation. These sections were immediately immersed
in Millonig's phosphate buffer, pH 7.3, at 4°C for 5 sec,
then transferred to a drop of Karnovsky's fixative at
4°C and mincedinto 1-m2pieces. After24 hroffurther
fixation in Karnovsky's fixative at 4°C, these sections
were postfixed in 2% buffered osmium tetroxide, de-
hydrated inethanol, and embedded inSpurrepoxyresin
(Electron Microscopy Sciences, Fort Washington, PA)
with the skin oriented to allow perpendicular cuts. Six
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FIGURE 1. Effect of repetitive treatments of 1000 ppm HOCI on
epidermal thickness. Animals were sacrificed 24 hr following final
treatment. Zero (0) days represents nontreated animals that were
sacrificed onday 1. Watercontrol animals received 8days oftreat-
ment and were sacrificed on day 9. The thickness ofthe IFE was
measured with an eyepiece micrometerat x400. Valuesrepresent
the group mean ± SE. N = 5.
nonserial 1.0-,um sections from each block were cut,
stained with 1% toluidine blue, and examined with a
light microscope. Epidermal thickness and the cell
counts were measured at x400 with an eyepiece mi-
crometer.
Results
Figure 1 depicts the effect of multiple treatments of
1000 ppm HOCl on epidermal thickness measured 1 day
afterthe last treatment. From these data we concluded
that four repeated daily 10-min applications of HOCl
provided a maximal response. This period of exposure
substantially depletes the HOCI concentration (i.e., >
70%); consequently, using longer exposure periods in
this staticsystemwaspointless. Themaximalepidermal
thickness observed was 38.7 ,um (± 4.0 SE) compared
to 13.8 ,um (+ 1.1 SE) for animals exposed to distilled
water treatments.
The hyperplasiogenic activity of the four alternative
disinfectant solutions tested in the primary study is
summarized in Table 1. The epidermal layer in control
animals measured 15.4 ,um. When fourdailytreatments
of 1, 10, 100, 300, and 1000 ppm HOCl were applied and
animals were sacrificed on day 5, results for 1 and 10
ppm were not unlike those of controls (14.4 and 15.8
,um), but 100, 300, and 1000 ppm progressively in-
creased skin thickness to 21.9, 30.0, and 38.7 ,um (sig-
nificant at p < 0.05), respectively. In contrast, when
animals were exposed for 4 days to OCl- (pH 8.5) at a
concentration of 1000 ppm and sacrificed on day 5, the
epidermalthickness was increased to only25.0 ,um. The
results observed with C102 treatment were similar to
those found with HOCl treatment. Treatments of1, 10,
100, 300, 1000 ppm C102 followed by sacrifice on day 5
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Table 1. Skin hyperplasia produced by alternate drinking water disinfectants-dose response.
Epidermal Cell count/mm Dose Days of thickness,Celcutm
Treatment ppma treatment tMb Total Basal
Control (H2O) 4 15.4 ± 1.5 38 ± 6.8 24 ± 3.5
Chlorine pH 6.5 1000 4 38.7c ± 7.0 62d 19.3 27 ± 4.1
300 4 30.0 ± 13.0 77d 14.0 33d 7.0
100 4 15.8±2.5 40±5.2 24 ±5.0
1 4 14.4±1.7 37±6.4 25 ±4.7
Chlorine pH 8.5 1000 4 25.Oc ± 6.2 61d 8.8 25 ± 5.7
Chlorine dioxide 1000 4 40.2c ± 11.8 70d ± 9.0 32d ± 6.2
300 4 16.8 ± 0.8 77 + 11.0 35 ± 5.0
100 4 13.5±2.2 37± 6.0 25 ±3.2
10 4 15.0± 1.2 37±3.7 26 ±4.4
1 4 15.5±2.5 38± 5.3 26 ±2.6
Chloramine 1000 4 13.6 ± 6.1 35 ± 3.6 25 ± 2.8
100 4 13.1±2.3 35±3.0 22 ±2.1
10 4 14.4± 1.1 37±5.0 25 ±4.1
1 4 14.0± 1.6 36±6.3 21 ±2.0
TPA 1.0 ,ug 1 32.8 ± 3.4 43d ± 5.7 20 ± 3.5
aWhole body (except head) exposure to solutions consisted of 10 min contact time per day of treatment in plexiglass chambers designed to
protect animals from toxic vapors. TPA was administered topically to the back of the animals. (N = 5).
bThickness of IFE was measured at x 600 with light microscopic using an eyepiece micrometer. Values shown are mean per group ±
standard deviation.
'Significant at p < 0.05. Statistical analyses were performed using Tukey's multiple comparison test.
dSignificantly different from control at p < 0.05. Statistical analyses were performed using Tukey's multiple comparison test.
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FIGURE 2. Time course of hyperplasiogenic response of the SEN-
CAR mouse skin after asingle treatment with (A) 1000 ppm HOCl
(A), NaOCI (C]), C102 (0), or distilled H20 (0) control for HOCl
and C102 (0) control for NaOCI; (B) 2.5 ,ug 12-0-tetradecanoyl-
phorbol-13-acetate (TPA). There were five animals per treatment
group at each time of sacrifice. Animals were sacrificed and skin
thickness measurements made at the indicated intervals following
treatment. Measurements represent average thickness ofIFE de-
termined with an eyepiece micrometer at x 400. Values represent
the group mean + SE.
did not increase epidermal thickness at the four lower
doses (15.5, 15.0, 16.8, and 13.5 ,um), but did result in
a significant response (p < 0.05) at the high dose (40.8
um). NH2Cl, atalldoselevels, demonstrated atendency
to decrease epidermal thickness, although not signifi-
cantly below controls. A single dose of TPA at 1.0 ,ug
yielded a skin thickness of 32.8 + 3.4 urm on the fifth
experimental day.
Cell counts (Table 1) indicate that proliferative activ-
ity contributes to the hyperplasiogenic action ofthe dis-
infectant agents. To demonstrate this proliferation, the
effect of the most active disinfectant doses (1000 ppm
x 4) were compared with those of the vehicle control
(H20). There were 62/27 (total/basal) cells per linear
millimeter with HOCI, 61/25 with OCl-, 70/32 with
C102, and 35/25 with NH2Cl, compared to 38/24 cell/mm
with distilled water treatments. TPA treatment re-
sulted in 43/20 cells/mm.
It is obvious that the cell counts for OCl- are not
consistent with the reduced IFE thickness resulting
from 1000 ppm OCl- (Table 1). When compared to cell
count/epidermal thickness relationship noted in groups
receiving HOC1 or C102 as the same dose level. Cell
counts for OCl- (61/25-total/basal) were similar to
counts found in HOCI and C102 (62/27 and 70/32, re-
spectively). The IFE thickness ofOCl- treated groups
(25 + 6.2 um), however, is only 64% of the measure-
ment seen with HOCI and C102 (38.7 + 7.0 and 40.2 +
11.8 ,um, respectively). This discrepancy is explained in
part by the presence of an increased number of small
cells in the stratum spinosum of skin sections from the
OCl- group compared to sections from HOCl- and C102-
treated animals. Various combinations ofchanges inthe
basal layer such as widening and narrowing of elonga-
tion of cells and the degree of intracellular space may
accountforthe differencesnoted inthebasalcell counts.
The low basal cell count noted in the TPA 1.0 ,ug group
(20 + 3.5 ,um) could possibly be explained by the pres-
ence ofelongated, wide basal cells with prominent gaps
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FIGURE 3. Micrographs depicting thickness of IFE of SENCAR mouse skin after four daily 10-min whole body (except head) treatments
with 1000 ppm solutions of (A) HOCI, (B) C102, (C) NH2C1, (D) distilled water or (E) TPA 2.5 ,ug/mouse in 0.2 mL acetone applied to back
only. x 600 except (E) which is x 950. Note similarity ofepidernal layer ofHOC1- (A) and C102-(B) treated skin to that treated with TPA
(E). Observable in these sections are increased cell layers, enlarged round cells and elongated basal cells. Some dark cells are present but
were not quantified in this study. Note also the tendency for reduced IFE thickness associated with NH2Cl treatment (C) as compared to
control (D).
between cells. This is in contrast to the higherbasal cell
count observed in HOCI, OCI-, and C102 groups re-
ceiving 1000 ppm solutions (27 + 4.1, 25 + 5.7, and 32
± 6.2 jim, respectively). Elongation ofbasal cells does
not occur in animals treated with only water. Final ex-
planation of the exact association between cell count
and induced epidermal thickness may require more de-
tailed study possibly using morphometric analysis pro-
cedures.
The hyperplastic responsemeasured throughout a 12-
day recovery period following a single treatment of
HOCI, NaOCI, or C102 at 1000 ppm is presented in
Figure 2. There were five animals per treatment per
day ofevaluation. Again HOCI resulted in the greatest
response elicited by the disinfectant agents (30.8 ,um),
nearly equaling that of TPA (32.8 ,um). The response
to HOCI, however, was delayed for 4 days whereas
maximum response to TPA occurred on the second day.
The hyperplasiaresultingfromHOCl exposure was sus-
tained considerably longer than that associated with
TPA treatment. The epidermal thickness after TPA
treatment peaked at 32.8 ,um on day 2 and dropped
sharply to 22. 7 ,um on day 3. Thereafter, it gradually
decreased to 16.6 jim on day 12. The thickness associ-
ated with HOCl treatment peaked significantly on day
8 at 30.8 jim after a sharp increase to 26.8 jim on day
4 (p < 0.05) and was still at 26.1 ,um on day 10 before
falling to 19.1 ,um on day 12. The increase with both
NaOCl and C102 was less than with HOCI, but was
significant (p < .05) and was sustained throughout the
12-day period, with the highest values reached at day
10 (18.2 jim) and day 12 (19.8 jim), respectively. The
phase one control values ranged from 11.2 jim (day 8)
to 12.6 jim (day 1). The phase twocontrolvaluesranged
from 9.7 jim (day 12) to 14.3 jim (day 1).
The morphological features of the epidermal hyper-
plasia are demonstrated in Figure 3. The morphological
changes observed after treatment with HOCI or C102
are similar to those found 24 to 48 hr after TPA treat-
ment (4). These changes include a thickened epidermis,
4 to 6 celllayersthick, consistingofenlarged round cells
with prominent, intracellular bridges and hyperkera-
tosis. The basal cells, containing oval nuclei, are elon-
gated and lie perpendicular tothe basementmembrane.
These changes, comparable to those produced by TPA,
are more evident in the C102 group than in the HOCl
group. The epidermis of mice treated with NH2Cl is
reduced in thickness but otherwise is not remarkably
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different when compared to the epidermis of animals
receiving distilled water.
Discussion
The present work demonstrated that briefexposures
of mouse skin to relatively high concentrations ofmost
of the drinking water disinfectants evaluated resulted
in hyperplastic responses. The major exception to this
observation was NH2Cl, which failed to increase epi-
dermal thickness or cell counts at concentrations of up
to 1000 mg/L. C102 and both forms of chlorine (HOCI
and OCI-) increased cell counts to an equivalent extent
at 1000 mg/L, but the increase of the thickness of the
epidermal layer observed with OCl- was only 40% of
that observed with HOCI and C102. The sections used
in these preliminary experiments are currently
undergoing review to determine whether the differ-
ences in epidermal thickness reflect differences in cel-
lular density or cell size in the OCI--treated animals.
The maximal hyperplastic response to HOCl initially
appeared to be dependent on multiple applications.
However, subsequent experimentation made it clear
that the response to a single application was delayed
relative to the response to TPA. Consequently, it is not
clear that four treatments are required for maximal
response. In contrast, the application ofa single treat-
ment ofOCl- or C102produced anincrease in epidermal
thickness that could be observed within 24 hr and that
was maintained for 12 days. Comparing the data follow-
ing 1 day of teatment for these latter two compounds
with those observed with fourrepeated treatments (Ta-
ble 1) indicates that a maximal response requires either
repeated or more prolonged exposures. The rapid de-
pletion of active chlorine from HOCI, OCI-, and C102
(but not from NH2Cl) does not allow differentiation be-
tween these two possibilities. In all cases, the role of
concentration versus dose needs to be further explored
experimentally.
Within the conditions of the present study, HOCI is
clearly the more potent hyperplasiogenic compound
studied. It increased epidermal thickness at levels as
low as 300 mg/L with four daily, 10-min treatments.
The extent to which this result might be extended to
lower concentrations with more prolonged exposures,
with some provision formaintaining a constant chlorine
residual, remains to be determined. Somewhat surpris-
ingly, repeated applications of HOCI at 1000 mg/L did
not appear to be particularly effective in maintaining
the maximal response. This lack of effectiveness may
be attributed to either ineffective penetration of the
reactive species through the hyperplastic skin (i.e., a
type of adaptation) or toxicity to the surface layer of
cells causing more rapid loss of these cells with subse-
quent treatments.
Pfeiffer (2) examined the effects of repeated topical
applications of 1% NaOCI (approximately 0.2 mg free
Clperanimal) and NH2Cl solutions to the skin ofNMRI
mice. Neither OCl- nor NH2Cl appeared to influence
the development of tumors significantly, whether ap-
plied before, with, or after applications of
benzo(a)pyrene. Priorworkby Hyatsu (3) had indicated
that NaOCI (approximately 5 mg per mouse per dose)
did enhance the development of tumors initiated by 4-
nitroquinoline-1-oxide. More recent work by Kurokawa
(7) involved the application of 0.2 mL of 1% NaOCl in
acetone (20 mg per animal per dose) and failed to find
evidence of tumor promotion in 7,12-dimethyl-
benz(a)anthracene-initiated mice. However, this latter
studydidnotdocumenttheimpact oftheorganicsolvent
(acetone) on the free residual chlorine dose applied to
the animals' skin.
It is difficult to compare the results of the present
work with these prior studies because of the differing
endpoints and method of application. The methodology
used in the present study provides a reservoir ofactive
chlorine for some minutes, whereas the doses admin-
istered in these prior studies are most likely dissipated
within seconds by reaction with organic material on the
skin surface. Therefore, althoughthe concentrations ap-
plied in the present study are much less than those used
in the prior studies, the effective dose might well be
higher. It must also be pointed out that these studies
addressed the effects of OCl- only. The present work
clearlyindicates that HOCIisthemorehyperplasiogenic
form of aqueous chlorine.
The ability of disinfectant to produce epidermal hy-
perplasia is of concern because of the excellent corre-
lationbetweenthisactivityandtumor-promotingability
among phorbol esters (5,6). However, this correlation
does not hold for compounds of other chemical classes.
Sincethe experimentsreported here do indicate an abil-
ity ofdisinfectants to produce epidermal hyperplasia, it
isimportant that theyalso be evaluated fortheirtumor-
promoting potential in the skin.
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